|
JPH05236966A
(ja)
*
|
1991-04-25 |
1993-09-17 |
Chugai Pharmaceut Co Ltd |
ヒトインターロイキン−6レセプターに対するマウスモノクローナル抗体の可変領域をコードするdna
|
|
AU668349B2
(en)
*
|
1991-04-25 |
1996-05-02 |
Chugai Seiyaku Kabushiki Kaisha |
Reconstituted human antibody against human interleukin 6 receptor
|
|
FR2694767B1
(fr)
*
|
1992-08-13 |
1994-10-21 |
Innotherapie Lab Sa |
Anticorps monoclonaux anti-IL6R, et leurs applications.
|
|
WO1995009873A1
(en)
*
|
1993-10-06 |
1995-04-13 |
Board Of Regents, The University Of Texas System |
A monoclonal anti-human il-6 receptor antibody
|
|
US8017121B2
(en)
|
1994-06-30 |
2011-09-13 |
Chugai Seiyaku Kabushika Kaisha |
Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
|
|
US6355237B1
(en)
|
1994-09-14 |
2002-03-12 |
Progenitor, Inc. |
Methods for using the obese gene and its gene product to stimulate hematopoietic development
|
|
US6451523B1
(en)
|
1994-09-14 |
2002-09-17 |
Interneuron Pharmaceuticals, Inc. |
Detection of a leptin receptor variant and methods for regulating obesity
|
|
US5912123A
(en)
*
|
1994-09-14 |
1999-06-15 |
Progenitor, Inc. |
Detection of the leptin receptor in reproductive organs and methods for regulating reproductive biology
|
|
US5763211A
(en)
*
|
1994-09-14 |
1998-06-09 |
Progenitor, Inc. |
Isolated nucleic acid encoding Hu-B1.219, a novel human hematopoietin
|
|
US5643748A
(en)
|
1994-09-14 |
1997-07-01 |
Progenitor, Inc. |
HU-B1.219, a novel human hematopoietin receptor
|
|
US5856098A
(en)
*
|
1994-09-14 |
1999-01-05 |
Progenitor, Inc. |
Detection of a leptin receptor variant
|
|
AU700819B2
(en)
*
|
1994-10-07 |
1999-01-14 |
Chugai Seiyaku Kabushiki Kaisha |
Rheumatoid arthritis remedy containing IL-6 antagonist as effective component
|
|
PL182089B1
(en)
*
|
1994-10-21 |
2001-11-30 |
Chugai Pharmaceutical Co Ltd |
Pharmaceutic compositions for treating diseases caused by production of il-6
|
|
JP3458512B2
(ja)
*
|
1995-02-23 |
2003-10-20 |
東ソー株式会社 |
骨密度の変動推定方法又は骨そしょう症の診断方法及びこれに用いる試薬キット
|
|
AU1833197A
(en)
*
|
1996-01-18 |
1997-08-11 |
Progenitor, Inc. |
Detection of a leptin receptor variant and methods for regulating obesity
|
|
DK0923941T3
(da)
|
1996-06-27 |
2006-09-18 |
Chugai Pharmaceutical Co Ltd |
Midler mod myelom der skal anvendes sammen med nitrogensennepantitumormidler
|
|
US8632778B2
(en)
|
2000-08-11 |
2014-01-21 |
Chugai Seiyaku Kabushiki Kaisha |
Stabilized anti-interleukin-6 antibody-containing preparations
|
|
AU1095202A
(en)
|
2000-10-25 |
2002-05-06 |
Chugai Pharmaceutical Co Ltd |
Preventives or remedies for psoriasis containing as the active ingredient il-6 antagonist
|
|
UA80091C2
(en)
|
2001-04-02 |
2007-08-27 |
Chugai Pharmaceutical Co Ltd |
Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
|
|
GB2401040A
(en)
|
2003-04-28 |
2004-11-03 |
Chugai Pharmaceutical Co Ltd |
Method for treating interleukin-6 related diseases
|
|
MXPA06003768A
(es)
|
2003-10-17 |
2006-06-23 |
Chugai Pharmaceutical Co Ltd |
Agente terapeutico para el mesotelioma.
|
|
RU2450830C2
(ru)
|
2005-10-21 |
2012-05-20 |
Чугаи Сейяку Кабусики Кайся |
Средства для лечения кардиопатии
|
|
AR057582A1
(es)
|
2005-11-15 |
2007-12-05 |
Nat Hospital Organization |
Agentes para suprimir la induccion de linfocitos t citotoxicos
|
|
WO2007061029A1
(ja)
|
2005-11-25 |
2007-05-31 |
Keio University |
前立腺癌治療剤
|
|
JP5033643B2
(ja)
|
2006-01-27 |
2012-09-26 |
学校法人慶應義塾 |
脈絡膜血管新生を伴う疾患の治療剤
|
|
JP5754875B2
(ja)
|
2006-04-07 |
2015-07-29 |
国立大学法人大阪大学 |
筋再生促進剤
|
|
US8080248B2
(en)
|
2006-06-02 |
2011-12-20 |
Regeneron Pharmaceuticals, Inc. |
Method of treating rheumatoid arthritis with an IL-6R antibody
|
|
ATE537190T1
(de)
|
2006-06-02 |
2011-12-15 |
Regeneron Pharma |
Hochaffine antikörper gegen den humanen il-6- rezeptor
|
|
CN101528778A
(zh)
*
|
2006-08-18 |
2009-09-09 |
埃博灵克斯股份有限公司 |
用于治疗与il-6-介导的信号传导相关的疾病和病症的针对il-6r的氨基酸序列以及包括其的多肽
|
|
JP2010500876A
(ja)
|
2006-08-18 |
2010-01-14 |
アブリンクス エン.ヴェー. |
Il−6媒介性シグナル伝達に関連する疾患及び障害の治療のための、il−6rに指向性を有するアミノ酸配列及びこれを含むポリペプチド
|
|
CA2672386A1
(en)
*
|
2006-12-13 |
2008-06-19 |
Ablynx N.V. |
Polypeptides specific for complexes involved in receptor-mediated signaling, such as the il-6/il-6 receptor complex
|
|
EP2174667B1
(de)
|
2007-07-26 |
2017-01-04 |
Osaka University |
Mittel zur behandlung von augenentzündungen mit interleukin-6-rezeptorhemmer als wirkstoff
|
|
BRPI0817482B8
(pt)
|
2007-10-02 |
2021-05-25 |
Chugai Pharmaceutical Co Ltd |
uso de um anticorpo do receptor da interleucina-6 (il-6) no tratamento da doença do enxerto versus hospedeiro (gvhd)
|
|
JP2011520898A
(ja)
|
2008-05-13 |
2011-07-21 |
ノビミューン エスアー |
抗il−6/il−6r抗体およびそれらの使用方法
|
|
TW201503898A
(zh)
|
2008-06-05 |
2015-02-01 |
Chugai Pharmaceutical Co Ltd |
神經浸潤抑制劑
|
|
MX2011010681A
(es)
|
2009-04-10 |
2012-01-20 |
Ablynx Nv |
Secuencias mejoradas de aminoacidos dirigidas contra il-6r y polipeptidos que comprenden el mismo para el tratamiento de enfermedades y trastornos relacionados con il-6r.
|
|
WO2010115995A2
(en)
|
2009-04-10 |
2010-10-14 |
Ablynx Nv |
Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
|
|
SG178190A1
(en)
|
2009-07-31 |
2012-03-29 |
Shin Maeda |
Cancer metastasis inhibitor
|
|
US20110117087A1
(en)
|
2009-10-26 |
2011-05-19 |
Reinhard Franze |
Method for the production of a glycosylated immunoglobulin
|
|
JO3417B1
(ar)
|
2010-01-08 |
2019-10-20 |
Regeneron Pharma |
الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r
|
|
RS63800B1
(sr)
|
2010-05-28 |
2022-12-30 |
Chugai Pharmaceutical Co Ltd |
Poboljšanje antitumorskog odgovora t ćelije
|
|
WO2013041722A1
(en)
|
2011-09-23 |
2013-03-28 |
Ablynx Nv |
Prolonged inhibition of interleukin-6 mediated signaling
|
|
TWI589299B
(zh)
|
2011-10-11 |
2017-07-01 |
再生元醫藥公司 |
用於治療類風濕性關節炎之組成物及其使用方法
|
|
EP3009518B1
(de)
|
2013-06-11 |
2020-08-12 |
National Center of Neurology and Psychiatry |
Verfahren zur vorhersage einer posttherapeutischen prognose von patienten mit schubförmig remittierender multipler sklerose (rrms) und verfahren zur bestimmung der anwendbarkeit der neuartigen therapie
|
|
JP6563910B2
(ja)
|
2013-07-04 |
2019-08-21 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
血清サンプル中の抗薬物抗体を検出するための干渉抑制イムノアッセイ
|
|
DE202014010499U1
(de)
|
2013-12-17 |
2015-10-20 |
Kymab Limited |
Targeting von humaner PCSK9 zur Cholesterinbehandlung
|
|
US9017678B1
(en)
|
2014-07-15 |
2015-04-28 |
Kymab Limited |
Method of treating rheumatoid arthritis using antibody to IL6R
|
|
CA2963712A1
(en)
|
2014-10-21 |
2016-04-28 |
Ablynx Nv |
Treatment of il-6r related diseases
|
|
EP3620531A4
(de)
|
2017-05-02 |
2021-03-17 |
National Center of Neurology and Psychiatry |
Verfahren zur vorhersage und beurteilung der therapeutischen wirkung bei erkrankungen im zusammenhang mit il-6 und neutrophilen
|
|
TWI822728B
(zh)
|
2018-01-31 |
2023-11-21 |
加藤元一 |
含有il-6抑制劑的哮喘治療劑
|
|
JP7542543B2
(ja)
|
2019-01-31 |
2024-08-30 |
サノフィ・バイオテクノロジー |
若年性特発性関節炎を治療するための抗il-6受容体抗体
|
|
JP2022545312A
(ja)
|
2019-04-24 |
2022-10-27 |
サノフィ・バイオテクノロジー |
関節リウマチの診断及び処置の方法
|
|
CA3142710A1
(en)
|
2019-06-04 |
2020-12-10 |
Sanofi Biotechnology |
Compositions and methods for treating pain in subjects with rheumatoid arthritis
|
|
WO2022129572A1
(en)
|
2020-12-18 |
2022-06-23 |
Ablynx Nv |
Polypeptides comprising immunoglobulin single variable domains targeting il-6 and tnf-alpha
|
|
WO2025198912A1
(en)
|
2024-03-21 |
2025-09-25 |
Hoffmann-La Roche Inc. |
Methods of treating myasthenia gravis
|